Li-Shan Huang
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Food Contamination | 7 | 2003 | 18 |
Why?
|
Methylmercury Compounds | 8 | 2003 | 25 |
Why?
|
Child Development | 7 | 2003 | 49 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2003 | 46 |
Why?
|
Models, Statistical | 3 | 2003 | 114 |
Why?
|
Environmental Exposure | 5 | 2003 | 75 |
Why?
|
Seafood | 3 | 2003 | 8 |
Why?
|
Carbon | 6 | 2004 | 30 |
Why?
|
Maternal Exposure | 2 | 2005 | 24 |
Why?
|
Water Pollutants, Chemical | 1 | 2007 | 9 |
Why?
|
Motor Activity | 1 | 2007 | 104 |
Why?
|
Maternal-Fetal Exchange | 2 | 2003 | 49 |
Why?
|
Seychelles | 7 | 2003 | 12 |
Why?
|
Fishes | 4 | 2003 | 20 |
Why?
|
Environmental Pollutants | 1 | 2005 | 35 |
Why?
|
Pregnancy | 10 | 2003 | 455 |
Why?
|
Air Pollutants | 3 | 2006 | 42 |
Why?
|
Desipramine | 2 | 2009 | 20 |
Why?
|
Nutritional Status | 2 | 2008 | 27 |
Why?
|
Hair | 5 | 2003 | 23 |
Why?
|
Lidocaine | 2 | 2009 | 49 |
Why?
|
Antigens, CD44 | 2 | 2008 | 18 |
Why?
|
Particulate Matter | 2 | 2008 | 22 |
Why?
|
Female | 22 | 2003 | 1643 |
Why?
|
Inhalation Exposure | 3 | 2004 | 22 |
Why?
|
Infant | 6 | 2003 | 464 |
Why?
|
Child | 7 | 2003 | 749 |
Why?
|
Uterine Prolapse | 2 | 2005 | 8 |
Why?
|
Cohort Studies | 6 | 2003 | 332 |
Why?
|
Follow-Up Studies | 5 | 2003 | 553 |
Why?
|
Neuropsychological Tests | 4 | 2006 | 113 |
Why?
|
Humans | 24 | 2003 | 1856 |
Why?
|
Regression Analysis | 4 | 2003 | 256 |
Why?
|
Anesthetics, Local | 2 | 2009 | 50 |
Why?
|
Prostatic Neoplasms | 2 | 2008 | 120 |
Why?
|
Asthma | 3 | 2004 | 97 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2011 | 15 |
Why?
|
Child, Preschool | 3 | 2003 | 554 |
Why?
|
2-Propanol | 1 | 2010 | 5 |
Why?
|
Disinfection | 1 | 2010 | 9 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2010 | 9 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 39 |
Why?
|
Erythroblasts | 1 | 2011 | 13 |
Why?
|
Adult | 12 | 2003 | 1317 |
Why?
|
Vulvodynia | 1 | 2010 | 7 |
Why?
|
Laparotomy | 1 | 2010 | 24 |
Why?
|
Sarcoma | 1 | 2011 | 42 |
Why?
|
Coagulants | 1 | 2010 | 12 |
Why?
|
Surgical Instruments | 1 | 2010 | 35 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2010 | 18 |
Why?
|
Renal Dialysis | 1 | 2011 | 56 |
Why?
|
Achievement | 1 | 2010 | 28 |
Why?
|
Male | 15 | 2003 | 1553 |
Why?
|
Delivery, Obstetric | 2 | 2005 | 21 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 64 |
Why?
|
Neuroendocrine Tumors | 1 | 2009 | 4 |
Why?
|
Blood Vessels | 1 | 2010 | 65 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2009 | 6 |
Why?
|
Bacterial Infections | 1 | 2010 | 88 |
Why?
|
Vulvar Diseases | 1 | 2009 | 19 |
Why?
|
Parity | 2 | 2005 | 28 |
Why?
|
Developmental Disabilities | 1 | 2010 | 54 |
Why?
|
Carcinoma, Small Cell | 1 | 2008 | 20 |
Why?
|
Particle Size | 5 | 2004 | 55 |
Why?
|
Time Factors | 4 | 2006 | 896 |
Why?
|
Neoplastic Stem Cells | 1 | 2009 | 21 |
Why?
|
Hyperemia | 1 | 2008 | 18 |
Why?
|
Mercury Poisoning, Nervous System | 1 | 2008 | 8 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2009 | 23 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 78 |
Why?
|
Selenium | 1 | 2007 | 15 |
Why?
|
Intelligence Tests | 1 | 2007 | 22 |
Why?
|
Reproducibility of Results | 3 | 2003 | 391 |
Why?
|
Metal Nanoparticles | 1 | 2007 | 10 |
Why?
|
Pain Measurement | 1 | 2009 | 98 |
Why?
|
Cluster Analysis | 1 | 2007 | 66 |
Why?
|
Intelligence | 1 | 2007 | 43 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2007 | 431 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 127 |
Why?
|
Space Perception | 1 | 2008 | 36 |
Why?
|
Double-Blind Method | 4 | 2009 | 274 |
Why?
|
Smoking | 1 | 2011 | 153 |
Why?
|
Social Environment | 1 | 2007 | 58 |
Why?
|
Psychomotor Performance | 1 | 2008 | 69 |
Why?
|
Visual Perception | 1 | 2008 | 51 |
Why?
|
Gravidity | 1 | 2005 | 6 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 144 |
Why?
|
Urinary Incontinence, Stress | 1 | 2005 | 7 |
Why?
|
Tumor Markers, Biological | 1 | 2008 | 112 |
Why?
|
Young Adult | 4 | 2008 | 380 |
Why?
|
Zinc Oxide | 1 | 2005 | 8 |
Why?
|
Pain | 1 | 2009 | 191 |
Why?
|
Lead | 1 | 2007 | 55 |
Why?
|
Fish Products | 1 | 2005 | 8 |
Why?
|
Models, Biological | 1 | 2010 | 410 |
Why?
|
Cognition | 1 | 2006 | 97 |
Why?
|
Leukocytes | 1 | 2006 | 94 |
Why?
|
Antigens, CD | 1 | 2006 | 128 |
Why?
|
Risk Assessment | 2 | 2003 | 324 |
Why?
|
Diet | 1 | 2003 | 87 |
Why?
|
Longitudinal Studies | 1 | 2003 | 195 |
Why?
|
Exercise | 3 | 2006 | 82 |
Why?
|
Immunohistochemistry | 3 | 2008 | 355 |
Why?
|
Research Design | 1 | 2003 | 169 |
Why?
|
Sputum | 3 | 2004 | 26 |
Why?
|
Cross-Over Studies | 2 | 2009 | 82 |
Why?
|
Mice | 1 | 2010 | 623 |
Why?
|
Animals | 5 | 2003 | 1031 |
Why?
|
Sex Factors | 2 | 2010 | 284 |
Why?
|
Flow Cytometry | 2 | 2009 | 216 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 243 |
Why?
|
Age Factors | 2 | 2010 | 480 |
Why?
|
Postmenopause | 2 | 2005 | 27 |
Why?
|
Middle Aged | 5 | 2004 | 1161 |
Why?
|
Adolescent | 3 | 2008 | 891 |
Why?
|
Respiratory System | 2 | 2004 | 30 |
Why?
|
Retrospective Studies | 2 | 2009 | 653 |
Why?
|
Case-Control Studies | 2 | 2004 | 283 |
Why?
|
Nitric Oxide | 2 | 2004 | 85 |
Why?
|
Treatment Outcome | 2 | 2009 | 661 |
Why?
|
Genes, myb | 1 | 2011 | 1 |
Why?
|
Hemoglobin A | 1 | 2011 | 4 |
Why?
|
Glycophorin | 1 | 2011 | 7 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 11 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 11 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2011 | 15 |
Why?
|
Gloves, Surgical | 1 | 2010 | 4 |
Why?
|
Bacteria, Aerobic | 1 | 2010 | 6 |
Why?
|
Asepsis | 1 | 2010 | 7 |
Why?
|
Systemic Vasculitis | 1 | 2010 | 6 |
Why?
|
Iodine | 1 | 2010 | 21 |
Why?
|
Choline | 1 | 2010 | 24 |
Why?
|
Docosahexaenoic Acids | 1 | 2010 | 8 |
Why?
|
Administration, Intravaginal | 1 | 2010 | 10 |
Why?
|
Karyotyping | 1 | 2011 | 47 |
Why?
|
P-Selectin | 1 | 2010 | 20 |
Why?
|
Immunophenotyping | 1 | 2011 | 66 |
Why?
|
Language Development | 1 | 2010 | 12 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 53 |
Why?
|
von Willebrand Factor | 1 | 2010 | 34 |
Why?
|
Arachidonic Acid | 1 | 2010 | 29 |
Why?
|
Gene Deletion | 1 | 2011 | 121 |
Why?
|
CD40 Ligand | 1 | 2010 | 51 |
Why?
|
Iron | 1 | 2010 | 75 |
Why?
|
Chromogranin A | 1 | 2009 | 8 |
Why?
|
Administration, Oral | 1 | 2010 | 170 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2009 | 24 |
Why?
|
Coitus | 1 | 2009 | 17 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 36 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2009 | 14 |
Why?
|
Bone Marrow | 1 | 2011 | 109 |
Why?
|
Silicones | 1 | 2009 | 20 |
Why?
|
Drug Synergism | 1 | 2009 | 104 |
Why?
|
Drug Combinations | 1 | 2009 | 95 |
Why?
|
Tissue Array Analysis | 1 | 2008 | 27 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2008 | 9 |
Why?
|
Forearm | 1 | 2008 | 25 |
Why?
|
Luminescence | 1 | 2007 | 3 |
Why?
|
Spectrum Analysis | 1 | 2007 | 26 |
Why?
|
Photons | 1 | 2007 | 13 |
Why?
|
Electrochemistry | 1 | 2007 | 32 |
Why?
|
Statistics as Topic | 1 | 2008 | 133 |
Why?
|
Hemodynamics | 1 | 2008 | 131 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 208 |
Why?
|
Heart Rate | 1 | 2009 | 138 |
Why?
|
Receptors, Nicotinic | 1 | 2006 | 15 |
Why?
|
Utah | 1 | 2005 | 8 |
Why?
|
Siblings | 1 | 2005 | 28 |
Why?
|
Cell Line | 1 | 2011 | 375 |
Why?
|
Dust | 1 | 2006 | 22 |
Why?
|
Prospective Studies | 1 | 2010 | 545 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 427 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 402 |
Why?
|
Age Distribution | 1 | 2005 | 127 |
Why?
|
Lymphocyte Subsets | 1 | 2004 | 26 |
Why?
|
Administration, Inhalation | 1 | 2005 | 60 |
Why?
|
Probability | 1 | 2005 | 190 |
Why?
|
Blood Coagulation | 1 | 2004 | 57 |
Why?
|
Cardiovascular System | 1 | 2004 | 40 |
Why?
|
Adenocarcinoma | 1 | 2008 | 167 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2004 | 12 |
Why?
|
Respiration | 1 | 2004 | 78 |
Why?
|
Breath Tests | 1 | 2004 | 22 |
Why?
|
Respiratory Function Tests | 1 | 2004 | 72 |
Why?
|
Leukocyte Count | 1 | 2004 | 94 |
Why?
|
Mercury Poisoning | 1 | 2003 | 7 |
Why?
|
Incidence | 1 | 2005 | 336 |
Why?
|
Biological Markers | 1 | 2004 | 262 |
Why?
|
Severity of Illness Index | 1 | 2005 | 358 |
Why?
|
Comorbidity | 1 | 2003 | 190 |
Why?
|
Cytokines | 1 | 2004 | 207 |
Why?
|
Questionnaires | 1 | 2005 | 360 |
Why?
|
Cognition Disorders | 1 | 2003 | 107 |
Why?
|
Electrocardiography | 1 | 2005 | 132 |
Why?
|
Inflammation | 1 | 2004 | 208 |
Why?
|
